Literature DB >> 28732241

Generation of skeletal myogenic progenitors from human pluripotent stem cells using non-viral delivery of minicircle DNA.

Jaemin Kim1, Vanessa K P Oliveira1, Ami Yamamoto1, Rita C R Perlingeiro2.   

Abstract

Currently, the most efficient and promising approach for generating large numbers of engraftable human skeletal myogenic progenitors from pluripotent stem cells requires the conditional in vitro overexpression of PAX7 using lentiviral vectors. Because a non-integrating approach would be preferable to eliminate or minimize the risk associated with random genomic integration, here we investigate whether transient expression of PAX7 using minicircle DNA would enable the generation of functional pluripotent stem cell-derived myogenic progenitors, equivalent to those generated by lentivirus. Our results demonstrate that upon multiple transfections, the minicircle approach allows for the scalable generation of myogenic progenitors and these undergo efficient terminal differentiation in vitro. However, transplantation of minicircle-generated myogenic progenitors resulted in limited engraftment. This is probably due to less efficient delivery and more transient PAX7 expression in these cultures since PAX7 downregulation is accompanied by high level of spontaneous differentiation. Thus, although the in vitro data shows that the minicircle approach could potentially replace the use of lentivirus, improvements in the transfection/expression system will be necessary before it will be a feasible strategy for the generation of myogenic progenitors for cell replacement therapy.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Engraftment; Lentivirus; Non-viral minicircle; Skeletal myogenic progenitors

Mesh:

Substances:

Year:  2017        PMID: 28732241      PMCID: PMC5582001          DOI: 10.1016/j.scr.2017.07.013

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  27 in total

1.  Pax7 is required for the specification of myogenic satellite cells.

Authors:  P Seale; L A Sabourin; A Girgis-Gabardo; A Mansouri; P Gruss; M A Rudnicki
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

Review 2.  Scaling-up recombinant plasmid DNA for clinical trial: current concern, solution and status.

Authors:  Ruzila Ismail; Zeenathul Nazariah Allaudin; Mohd-Azmi Mohd Lila
Journal:  Vaccine       Date:  2012-03-07       Impact factor: 3.641

3.  A common somitic origin for embryonic muscle progenitors and satellite cells.

Authors:  Jérôme Gros; Marie Manceau; Virginie Thomé; Christophe Marcelle
Journal:  Nature       Date:  2005-04-20       Impact factor: 49.962

Review 4.  Regulation of skeletal muscle stem cell behavior by Pax3 and Pax7.

Authors:  M Lagha; T Sato; L Bajard; P Daubas; M Esner; D Montarras; F Relaix; M Buckingham
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2008-11-06

Review 5.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

6.  PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic Progenitors.

Authors:  Alessandro Magli; Tania Incitti; James Kiley; Scott A Swanson; Radbod Darabi; Fabrizio Rinaldi; Sridhar Selvaraj; Ami Yamamoto; Jakub Tolar; Ce Yuan; Ron Stewart; James A Thomson; Rita C R Perlingeiro
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

7.  Functional myogenic engraftment from mouse iPS cells.

Authors:  Radbod Darabi; Weihong Pan; Darko Bosnakovski; June Baik; Michael Kyba; Rita C R Perlingeiro
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

8.  Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.

Authors:  Francesco Saverio Tedesco; Mattia F M Gerli; Laura Perani; Sara Benedetti; Federica Ungaro; Marco Cassano; Stefania Antonini; Enrico Tagliafico; Valentina Artusi; Emanuela Longa; Rossana Tonlorenzi; Martina Ragazzi; Giorgia Calderazzi; Hidetoshi Hoshiya; Ornella Cappellari; Marina Mora; Benedikt Schoser; Peter Schneiderat; Mitsuo Oshimura; Roberto Bottinelli; Maurilio Sampaolesi; Yvan Torrente; Vania Broccoli; Giulio Cossu
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

9.  Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation.

Authors:  Sébastien Goudenege; Carl Lebel; Nicolas B Huot; Christine Dufour; Isao Fujii; Jean Gekas; Joël Rousseau; Jacques P Tremblay
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

10.  Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells.

Authors:  Michael Shelton; Jeff Metz; Jun Liu; Richard L Carpenedo; Simon-Pierre Demers; William L Stanford; Ilona S Skerjanc
Journal:  Stem Cell Reports       Date:  2014-08-07       Impact factor: 7.765

View more
  8 in total

Review 1.  Recapitulating human myogenesis ex vivo using human pluripotent stem cells.

Authors:  Peggie Chien; Haibin Xi; April D Pyle
Journal:  Exp Cell Res       Date:  2021-12-30       Impact factor: 3.905

Review 2.  Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies.

Authors:  Rachel Lev; Dror Seliktar
Journal:  J R Soc Interface       Date:  2018-01       Impact factor: 4.118

Review 3.  Human muscle production in vitro from pluripotent stem cells: Basic and clinical applications.

Authors:  Lu Yan; Alejandra Rodríguez-delaRosa; Olivier Pourquié
Journal:  Semin Cell Dev Biol       Date:  2021-04-30       Impact factor: 7.727

Review 4.  Cell therapy to improve regeneration of skeletal muscle injuries.

Authors:  Taimoor H Qazi; Georg N Duda; Melanie J Ort; Carsten Perka; Sven Geissler; Tobias Winkler
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-03-06       Impact factor: 12.910

5.  Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9.

Authors:  Maggie C Walter; Volker Straub; Lindsay B Murphy; Olivia Schreiber-Katz; Karen Rafferty; Agata Robertson; Ana Topf; Tracey A Willis; Marcel Heidemann; Simone Thiele; Laurence Bindoff; Jean-Pierre Laurent; Hanns Lochmüller; Katherine Mathews; Claudia Mitchell; John Herbert Stevenson; John Vissing; Lacey Woods
Journal:  Ann Clin Transl Neurol       Date:  2020-04-28       Impact factor: 4.511

6.  Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7.

Authors:  Andreas Marg; Helena Escobar; Nikos Karaiskos; Stefanie A Grunwald; Eric Metzler; Janine Kieshauer; Sascha Sauer; Diana Pasemann; Edoardo Malfatti; Dominique Mompoint; Susanna Quijano-Roy; Anastasiya Boltengagen; Joanna Schneider; Markus Schülke; Séverine Kunz; Robert Carlier; Carmen Birchmeier; Helge Amthor; Andreas Spuler; Christine Kocks; Nikolaus Rajewsky; Simone Spuler
Journal:  Nat Commun       Date:  2019-12-18       Impact factor: 14.919

7.  Improving therapeutic potential of non-viral minimized DNA vectors.

Authors:  Lirio M Arévalo-Soliz; Cinnamon L Hardee; Jonathan M Fogg; Nathan R Corman; Cameron Noorbakhsh; Lynn Zechiedrich
Journal:  Cell Gene Ther Insights       Date:  2020-11-19

8.  Genomic Safe Harbor Expression of PAX7 for the Generation of Engraftable Myogenic Progenitors.

Authors:  Hyunkee Kim; Sridhar Selvaraj; James Kiley; Karim Azzag; Bayardo I Garay; Rita C R Perlingeiro
Journal:  Stem Cell Reports       Date:  2020-12-03       Impact factor: 7.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.